Related Experiment Videos
[Dehydroepiandrosterone (DHEA)--youth hormone?]
1Katedry i Kliniki Endokrynologii i Diabetologii Akademii Medycznej we Wrocławiu.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|April 4, 2002
Summary
Dehydroepiandrosterone (DHEA) and its metabolite (DHEA-S) decline with age, acting as potential biomarkers of aging. Research indicates DHEA counteracts age-related diseases and improves cognitive function, with potential for life extension.
Area of Science:
- Endocrinology and aging research.
Context:
- Dehydroepiandrosterone (DHEA) and its sulfated form (DHEA-S) are crucial steroid hormones produced by the adrenal cortex, gonads, and central nervous system (CNS).
- Hormone secretion patterns vary with age and sex, with DHEA and DHEA-S levels exhibiting a consistent decline throughout human lifespan.
Purpose:
- To highlight the significance of DHEA and DHEA-S as potential biomarkers for the aging process.
- To explore the multifaceted roles of DHEA in combating age-related diseases and influencing physiological functions.
Summary:
- DHEA and DHEA-S levels decrease systematically with age, suggesting their utility as aging biomarkers.
- Studies demonstrate DHEA's protective effects against conditions such as atherosclerosis, cancer, diabetes, insulin resistance, and obesity.
- DHEA also positively impacts mental well-being, cognitive functions, and memory.
Impact:
- DHEA replacement therapy shows promise in mitigating age-associated physiological decline and preventing age-related clinical disorders.
- Understanding DHEA's role may lead to interventions aimed at promoting healthy aging and longevity.
- Further research into DHEA's mechanisms could unlock new therapeutic strategies for age-related diseases.